Biomarin Pharmaceutical

BMRNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.267 B

$63.37 -1.08%

Close of 22 Sept 2026

Revenue

$3.22B

#873 by revenue

Earnings

$348.9M

#768 by earnings

Shares outstanding

193,573,759

Latest filing cover page

P/E ratio

35.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#28BridgeBio PharmaBBIO$13.5B
#29Corcept TherapeuticsCORT$12.7B
#30Biomarin PharmaceuticalBMRN$12.3B
#31Madrigal PharmaceuticalsMDGL$12.0B
#32Elanco Animal HealthELAN$11.5B

What if Biomarin Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $30.2T

$156,188.37

Per share 2,465× higher

Bitcoin $1.74T

$8,997.37

Per share 142× higher

Nvidia $5.52T

$28,494.39

Per share 450× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Biomarin Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.